Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
The Journal of Medical Humanities|September 3, 2013
Pharmaceutical ethics and physician liability in Side EffectsGaurav J Dhiman, Kyle T AmberAmerican Journal of Clinical Dermatology|September 21, 2015
Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ SubtypeKyle T Amber, Romi Bloom, Keyvan NouriThe Journal of Clinical and Aesthetic Dermatology|July 12, 2014
Injection therapy for the management of superficial subcutaneous lipomasKyle T Amber, Steven Ovadia, Ivan CamachoAntibodies (Basel, Switzerland)|July 27, 2022
Deciphering the Contribution of BP230 Autoantibodies in Bullous PemphigoidConnor Cole, Luca Borradori, Kyle T AmberItalian Journal of Dermatology and Venereology|November 12, 2020
Autoreactive T cells in pemphigus: perpetrator and targetLuca Scarsella, Robert Pollmann, Kyle T AmberLung|April 24, 2015
A Systematic Review of Patients with Mucocutaneous and Respiratory Complications in Paraneoplastic Autoimmune Multiorgan Syndrome: Castleman's Disease is the Predominant MalignancyJohn Lee, Romi Bloom, Kyle T AmberThe Australasian Journal of Dermatology|March 25, 2015
An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis?Romi Bloom, Kyle T Amber, Keyvan NouriJournal of Medical Ethics|February 5, 2014
Conflict of interest in online point-of-care clinical support websitesKyle T Amber, Gaurav Dhiman, Kenneth W GoodmanAmerican Journal of Clinical Dermatology|May 4, 2018
Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-AnalysisKhalaf Kridin, Arnon D Cohen, Kyle T AmberFrontiers in Immunology|June 20, 2018
Non-Desmoglein Antibodies in Patients With Pemphigus VulgarisKyle T Amber, Manuel Valdebran, Sergei A GrandoPageof 11